Significantly reduced duration of antibiotic prescription for erysipelas subsequent to the 2019 French guidelines on skin and soft tissue infection: A before-after study - 17/04/24
Highlights |
• | In 2019, The French Health Authority issued new guidelines on erysipelas antibiotic duration. |
• | A before-after study on compliance with the new guidelines was carried out. |
• | Antibiotic duration for erysipelas decreased by 25% after the new guidelines were issued. |
• | The fixed duration recommendation may have helped to reduce antibiotic duration. |
Abstract |
Background |
New skin and soft tissue infections (SSTI) guidelines were published in 2019 in France, changing the recommended duration for antibiotic treatment. The objective of the present study was to assess the impact of the publication of the 2019 French guidelines on SSTIs on the duration of antibiotic prescription for erysipelas.
Methods |
In a before-after study (a year before and a year after April 1st, 2019), we included all adult patients diagnosed with erysipelas in Reims University Hospital medical wards and the emergency department. We retrospectively retrieved antibiotic prescription duration in the patients’ medical files.
Results |
Among 50 patients in the “before” and 39 in the “after” group, the mean duration of antibiotic prescription was significantly shorter in the “after” group (9.4 ± 2.8 vs. 12.4 ± 3.8 days, p = 0.0001).
Conclusions |
A 25% decrease in the duration of antibiotic prescription for erysipelas was observed following the implementation of these guidelines, providing useful information for an antibiotic stewardship policy.
Le texte complet de cet article est disponible en PDF.Keywords : Erysipelas, Skin and soft tissue infection, Cellulitis, Antibiotic duration, Guidelines
Plan
Vol 54 - N° 3
Article 104887- avril 2024 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?